Correlates and Predictors of NT-proBNP in Life Insurance Applicants.


Journal

Journal of insurance medicine (New York, N.Y.)
ISSN: 0743-6661
Titre abrégé: J Insur Med
Pays: United States
ID NLM: 8401468

Informations de publication

Date de publication:
01 Jul 2023
Historique:
received: 17 10 2022
accepted: 03 03 2023
medline: 21 9 2023
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

-To document the various laboratory and demographic/historical correlates of NT-proBNP levels in applicants for life insurance, and to explore the accuracy of a prediction model based on those variables. -NT-proBNP blood test results were obtained from 1.34 million insurance applicants between the age of 50 and 85 years, beginning in 2003. Exploratory data analysis was carried out to document correlations with other laboratory variables, sex, age, and the presence of relevant diseases. Further, predictive models were used to quantify the proportion of the variance of NT-proBNP, which can be explained by a combination of these other, easier to determine variables. -NT-proBNP shows the expected, negative correlation with estimated glomerular filtration rate (eGFR) is markedly higher in those with a history of heart disease and is somewhat higher in those with a history of hypertension. A strong, unexpected, negative correlation between NT-proBNP and albumin was discovered. Of the variables evaluated, a multivariate adaptive regression spline (MARS) model automated selection procedure selected 7 variables (age, sex, albumin, eGFR, BMI, systolic blood pressure, cholesterol, and history of heart disease). Variable importance evaluation determined that age, albumin and eGFR were the 3 most important continuous variables in the prediction of NT-proBNP levels. An ordinary least squares (OLS) model using these same variables achieved a R-squared of 24.7%. -Expected ranges of NT-proBNP may vary substantially depending on the value of other variables in the prediction equation. Albumin is significantly negatively correlated with NT-proBNP levels. The reasons for this are unclear.

Identifiants

pubmed: 37725501
pii: 495853
doi: 10.17849/insm-50-1-65-73.1
doi:

Substances chimiques

pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0
Albumins 0

Types de publication

Journal Article

Langues

eng

Pagination

65-73

Informations de copyright

Copyright © 2023 Journal of Insurance Medicine.

Auteurs

Steven J Rigatti (SJ)

Rigatti - Founder, Rigatti Risk Analytics, LLC, Consultant Medical Director, Clinical Reference Laboratories, Lenexa KS.

Robert Stout (R)

Stout - Chief Scientific Officer/Laboratory Director, Clinical Reference Laboratories, Lenexa KS.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH